Enovis (NYSE:ENOV – Get Free Report) and Clover Health Investments (NASDAQ:CLOV – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, institutional ownership, dividends, analyst recommendations, risk and earnings.
Analyst Recommendations
This is a summary of current ratings and target prices for Enovis and Clover Health Investments, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Enovis | 1 | 0 | 7 | 1 | 2.89 |
| Clover Health Investments | 1 | 3 | 1 | 0 | 2.00 |
Enovis presently has a consensus target price of $45.17, suggesting a potential upside of 85.73%. Clover Health Investments has a consensus target price of $2.90, suggesting a potential downside of 16.43%. Given Enovis’ stronger consensus rating and higher probable upside, equities research analysts clearly believe Enovis is more favorable than Clover Health Investments.
Valuation and Earnings
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Enovis | $2.25 billion | 0.62 | -$1.18 billion | ($19.88) | -1.22 |
| Clover Health Investments | $1.92 billion | 0.95 | -$85.55 million | ($0.12) | -28.92 |
Clover Health Investments has lower revenue, but higher earnings than Enovis. Clover Health Investments is trading at a lower price-to-earnings ratio than Enovis, indicating that it is currently the more affordable of the two stocks.
Insider & Institutional Ownership
98.5% of Enovis shares are owned by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are owned by institutional investors. 2.9% of Enovis shares are owned by company insiders. Comparatively, 23.5% of Clover Health Investments shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Risk & Volatility
Enovis has a beta of 1.41, indicating that its stock price is 41% more volatile than the S&P 500. Comparatively, Clover Health Investments has a beta of 2.44, indicating that its stock price is 144% more volatile than the S&P 500.
Profitability
This table compares Enovis and Clover Health Investments’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Enovis | -49.92% | 10.32% | 4.57% |
| Clover Health Investments | -2.58% | -16.52% | -9.28% |
Summary
Enovis beats Clover Health Investments on 9 of the 15 factors compared between the two stocks.
About Enovis
Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.
About Clover Health Investments
Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.
Receive News & Ratings for Enovis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovis and related companies with MarketBeat.com's FREE daily email newsletter.
